Monday, October 26, 2026 · Daily editionET --:--:--

Finished

The Use of PARO to Decrease Agitation in Persons With Dementia and/or Delirium

NCT05565703 · University of Pennsylvania · Updated 10 June 2024

What is being tested
PARO Robotic Seal Intervention; Attention Control
For
Dementia; Delirium
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 60 years to 110 years. About 104 people. The full rules are on the registry page.
Where
United States
When
Starts or started 30 Oct 2018, ends 30 Oct 2023. Registered 4 Oct 2022.
Results
None posted yet.

In the researchers' words

This Clinical trial tests the efficacy of using the PARO robotic seal to decrease agitation in hospitalized older adults with dementia and/or delirium. This clinical trial also tests the efficacy of the cleaning protocol for the robot. This randomized control trial includes a one hour interaction with the PARO robot two days in a row compared to an attention control with the researcher sitting with the participant in their room for one hour two days in a row. The outcomes being evaluated include both qualitative and quantitative data. Qualitative data from videotaped interactions with the persons interacting with the PARO Robot include episodes of agitation, and emotional responses to the robot via facial expressions. The quantitative outcomes include the Agitation, use of 1:1 sitters, use of psychoactive medications and length of stay.
ClinicalTrials.gov, NCT05565703

Sites

  • Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania, United States